Vigamox 0.5% Ophthalmic Solution 5ml

Vigamox 5 mg/ml is a prescription antibacterial ophthalmic solution formulated for the targeted treatment of purulent bacterial conjunctivitis and superficial ocular infections caused by susceptible microbial strains. Powered by Moxifloxacin (0.5%), a fourth-generation fluoroquinolone, it acts by inhibiting bacterial enzymes essential for DNA replication and repair (topoisomerase II and IV), leading to rapid bactericidal action. Its physiological pH formulation ensures high ocular tolerance and rapid corneal penetration, packaged in a sterile 5 ml dropper bottle.

Key Benefits

• Provides rapid bactericidal activity against a broad spectrum of Gram-positive, Gram-negative, and atypical ocular pathogens.

• Effective against common conjunctivitis pathogens, including resistant Staphylococcus aureus and Streptococcus pneumoniae.

• Dual enzyme inhibition reduces the likelihood of bacterial resistance development.

• Fast ocular tissue penetration achieves high concentrations in the tear film, conjunctiva, and cornea.

• Formulated to match the natural pH and tonicity of the eye, minimizing stinging upon instillation.

Key Ingredients

• Moxifloxacin Hydrochloride (equivalent to 5 mg/ml or 0.5% Moxifloxacin): Fourth-generation synthetic fluoroquinolone antibacterial agent.

• Excipients & Buffers: Sodium chloride, boric acid, and purified water for osmotic balance and pH stabilization.

Key Features

• Product Type: Ophthalmic Antibacterial Solution (Prescription Medication)

• Suitable For: Adults, the elderly, and children (including infants) diagnosed with bacterial conjunctivitis under ophthalmic supervision

• Broad antimicrobial coverage with low resistance profile

• Preservative-free formulation (self-preserved by the active substance profile), gentle on the ocular surface

• Pack size: 5 ml sterile dropper bottle

How to Use

• Wash hands thoroughly before administration.

• Tilt head back, look upward, and gently pull down the lower eyelid to form a conjunctival pouch.

• Instill 1 drop into the affected eye(s) 3 times daily (morning, afternoon, and evening).

• Close eye gently and press the inner corner of the eyelid (nasolacrimal occlusion) for 1–2 minutes to minimize systemic absorption.

• Treatment duration is typically 5 to 7 days, continuing for 2 to 3 days after symptoms resolve, or as strictly directed by a physician.

• Avoid wearing contact lenses during active ocular infection.